NCT06371456

Brief Summary

Epidural anesthesia for pain control during normal vaginal delivery is a blind maneuver and so we need a confirmatory sign for being in the correct epidural space. Loss of resistance sign using air may guide us wrongly as it may occur if we entered into the paravertebral muscles or cavities in the interspinal ligaments. So, additional confirmatory sign beside loss of resistance sign by air is strongly needed. We noticed that after occurence of loss of resistance sign by air and insertion of the epidural catheter a dew was formed on the internal sides of the epidural catheter after aspiration to be sure that there are no blood or cerebrospinal fluid in the catheter. This dew formation (Ramy sign) is characteristic for air in the epidural space when transferred from the warm epidural space (temperature about 38-39 celsius degree) to the colder aspect of the catheter outside the patient which nearly has the same operating room temperature (22 celsius degree). This sign may be associated with correct placement and good function of the epidural catheter.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

April 14, 2024

Last Update Submit

April 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • appearance of the dew sign

    dew formation inside the outer portion of the epidural catheter near the patient

    immediately during aspiration of the epidural catheter

Secondary Outcomes (6)

  • epidurogram

    immediately after epidural catheter insertion

  • visual analogue score

    20 minutes after epidural injection by 10 milliliter bupivacaine 0.25%

  • mean blood pressure

    20 minutes after epidural injection by 10 milliliter bupivacaine 0.25%

  • mean blood pressure

    30 minutes after epidural injection by 10 milliliter bupivacaine 0.25%

  • heart rate

    20 minutes after epidural injection by 10 milliliter bupivacaine 0.25%

  • +1 more secondary outcomes

Study Arms (1)

epidural anesthesia

EXPERIMENTAL
Procedure: epidural catheter placement

Interventions

after sterilization of the back, local anesthesia injection (xylocaine 5 ml) at lumbar 4-5 level, then advancing the epidural needle till loss of resistance by air occurs and the epidural catheter inserted then aspiration through the catheter will be done to confirm that no accidental cerebrospinal fluid or blood are aspirated and to observe the dew sign inside the outer portion of the epidural catheter near the back of the patient

epidural anesthesia

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Parturient for normal vaginal delivery
  • American society of anesthesiologists 2

You may not qualify if:

  • patients refusal
  • back infection
  • anticoagulant non stopped
  • platelets count less than 100000
  • international normalization ratio more than 1.4
  • severe cardiac or respiratory diseases
  • haemodynamics unstable patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesia

Study Record Dates

First Submitted

April 14, 2024

First Posted

April 17, 2024

Study Start

June 1, 2024

Primary Completion

June 1, 2025

Study Completion

August 1, 2025

Last Updated

April 17, 2024

Record last verified: 2024-04